Перейти к основной навигации
Перейти к поиску
Перейти к основному содержанию
Сортировать по:
Keyphrases
Acute Kidney Injury
16%
Arterial System
11%
Cardiac Energetics
5%
Chronic Antibody-mediated Rejection
16%
Chronic Kidney Disease
33%
Combination Therapy
16%
Comorbidity
5%
Confidence Interval
8%
Dialysis
16%
Dialysis Patients
16%
Dialysis Treatment
20%
Disease Therapy
16%
Elastance
5%
Electronic Health Systems
20%
End-stage Renal Disease
26%
End-stage Renal Disease Patients
16%
Epidemiology
16%
Health Registries
16%
Hemodialysis
18%
Hemodynamic Status
5%
High Risk
8%
Incidence Rate
8%
Intradialytic
16%
Intravenous Immunoglobulin (IVIg)
16%
Isolated Structure
5%
Kazakh
8%
Kazakh Population
5%
Kazakhstan
33%
Kidney Dialysis
16%
Kidney Transplantation
18%
Late Diagnosis
16%
Left Ventricular End-diastolic Pressure
5%
Left Ventricular Mechanics
5%
Mortality Rate
12%
Older Patients
8%
Patient Enrollment
5%
Pediatric Nephrology
16%
Pressure-volume Loop
16%
Prevalence Rate
8%
Prognostic Value
16%
Renal Replacement Therapy
16%
Renal Transplant Recipients
16%
Risk of Death
8%
Rituximab
16%
Survival Probability
10%
Therapy Initiation
6%
Vascular Property
5%
Ventricular-arterial Coupling
16%
Worsening Heart Failure
5%
Young Ones
8%
INIS
antibodies
16%
comparative evaluations
10%
coupling
33%
data
22%
death
6%
dialysis
22%
diseases
72%
ees
8%
epidemiology
16%
evaluation
8%
filtration
6%
immunoglobulins
16%
injuries
5%
kazakhstan
33%
kidneys
100%
patients
59%
pediatrics
5%
therapy
40%
transplants
16%
values
33%
volume
20%
Medicine and Dentistry
Acute Kidney Injury
16%
Antibody Mediated Rejection
16%
Chronic Kidney Disease
33%
Cohort Effect
16%
Combination Therapy
16%
End Stage Renal Disease
35%
Erythromycin Ethylsuccinate
9%
Glomerular Filtration Rate
6%
Health System
8%
Hemodialysis
22%
Immunoglobulin
16%
Kidney Dialysis
16%
Kidney Graft
16%
Kidney Transplantation
18%
Mortality Rate
16%
Pediatric Nephrology
16%
Peritoneal Dialysis
5%
Prevalence
16%
Renal Replacement Therapy
38%
Rituximab
16%
Survival Rate
11%
